Description: Panelists examine various types of critical illness plans, its success in Canada and other markets, and the challenges and opportunities for the U.S. market.

Description: Critical illness policies pay a large lump sum based upon diagnosis of conditions such as heart attack, stroke, life-threatening cancer, kidney failure, etc. From Record of Society of Actuaries, Volume 26, No. 1, session 119PD of the Las Vegas Spring Meeting.

Description: This panel discussion addresses Critical Illness product design, marketing, trends and lessons learned from other countries. From the Record of the Society of Actuaries, Volume 27, No. 2, Session 20

Description: This session provides an overview of industry approaches to valuing the liabilities of nontraditional health products. Liabilities for losses that have been incurred but not reported and for losses that have been reported but not paid are examined. Includes a discussion on employer specific stop-loss, provider excess loss, critical illness and cancer insurance. From the Record of the Society of Actuaries, Volume 28, No. 2, Session 133

Description: Panelists discuss the current climate for Critical Illness insurance in the United States. Topics include product design, pricing, underwriting, and marketing high-end products. From Record of Society of Actuaries, Vol. 30, No. 3, Session 11

Description: Panel members provide an overview of current practices and breaking trends in the critical illness market. Topics for discussion include benefit design, pricing considerations, recent experience and long-term outlook for the product. From the Record of the Society of Actuaries, Volume 28, No. 2, Session 47

Description: The last three decades have witnessed an important rise in number of people with diabetes in Asia, especially Type 2 Diabetes. Like no other common condition, numerous innovations are currently entering the healthcare system that will soon have a significant impact on management of the condition. This presentation explores the role played by sensors/wearables, artificial intelligence, new drugs and diabetes apps. We assess the realistic potential of such advancements and give an outlook on medium-term pricing and product development.

Description: The panelists in this session discuss the current state of the CI market in the United States and Canada as well as an overview of seveal other countries. Specific topics to be addressed include product features, marketing and producer issues. From the Record of the Society of Actuaries, Volume 29, No. 2, Session 24

Description: This session explores the aspects and the issues of offering a critical illness product in various markets, including individual, group, worksite and direct response. From the Record of the Society of Actuaries, Volume 28, No. 3, Session 7

Description: Panelists address current issues of critical illness products including underwriting, state filing, distribution and marketing. From the Record of the Society of Actuaries, Volume 28, No. 1, Session 33